{"id":"W2048013288","doi":"10.1016/j.jpba.2007.12.025","title":"Development of a discriminating in vitro dissolution method for a poorly soluble NO-donating selective cyclooxygenase-2 inhibitor","year":2007,"lang":"en","type":"article","venue":"Journal of Pharmaceutical and Biomedical Analysis","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada); TransCanada (Canada)","funders":"","keywords":"Chemistry; Dissolution; Chromatography; Bioavailability; Solubility; Particle size; Dissolution testing; Dosage form; Pulmonary surfactant; In vivo; Granule (geology); High-performance liquid chromatography; Pharmacokinetics; Pharmacology; Biopharmaceutics Classification System; Biochemistry; Organic chemistry; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008096089,0.0002247452,0.0008290582,0.0008136783,0.0002077251,0.0000190473,0.0002011849,0.0003004378,0.00009423559],"category_scores_gemma":[0.0005978249,0.0001742213,0.0003788429,0.001290089,0.0002411678,0.0001701559,0.00009134284,0.0007743452,0.000002680219],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001668582,"about_ca_system_score_gemma":0.00017183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002709263,"about_ca_topic_score_gemma":0.00004355327,"domain_scores_codex":[0.9965039,0.0003995463,0.001738892,0.0002836349,0.0005084294,0.0005655508],"domain_scores_gemma":[0.9967436,0.001535289,0.0006795592,0.00006484107,0.0004311787,0.0005455877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004214385,0.001679542,0.002971446,0.0004452024,0.002804541,0.00006828624,0.003657562,0.00008300745,0.7676559,0.0001426357,0.0003142018,0.2159633],"study_design_scores_gemma":[0.009674342,0.0006802386,0.005984448,0.0002060347,0.00482722,0.0001339418,0.003546819,0.2653134,0.627468,0.0004588414,0.08097484,0.0007318736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8071476,0.0008712221,0.1895881,0.0008120447,0.0008514041,0.0003585037,0.00004661628,0.00001654278,0.000308016],"genre_scores_gemma":[0.9489321,0.00004425459,0.05017996,0.0003172508,0.0004044799,0.000009378895,0.00002124465,0.00001098842,0.00008031711],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2652304,"threshold_uncertainty_score":0.7104537,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08266611607901135,"score_gpt":0.451466959442713,"score_spread":0.3688008433637017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}